NCT05418829View on ClinicalTrials.gov

AT-007 in Adult Subjects With Classic Galactosemia (CG)

PHASE3UnknownINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

December 31, 2022

Conditions
Classic Galactosemia
Interventions
DRUG

AT-007

AT-007 20 mg/kg once daily

Trial Locations (1)

08009

Hassman Research Institute, Berlin

Sponsors
All Listed Sponsors
lead

Applied Therapeutics, Inc.

INDUSTRY